T J Matthews|C F Reich - JoVE Visualize

Showing results (121-130 of 161) with videos related to

Pageof 17

Sort By:

Journal of Virology|November 13, 1999

Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificityC C LaBranche, T L Hoffman, J Romano, et al.

AIDS Research and Human Retroviruses|May 19, 2006

Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2T Melby, P Sista, R DeMasi, et al.

Science (New York, N.Y.)|December 14, 1990

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1K Javaherian, A J Langlois, G J LaRosa, et al.

AIDS Research and Human Retroviruses|October 1, 1995

Induction of HIV type 1 neutralizing and env-CD4 blocking antibodies by immunization with genetically engineered HIV type 1-like particles containing unprocessed gp160 glycoproteinsB Rovinski, L Rodrigues, S X Cao, et al.

Virology|May 1, 1984

Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymusK J Weinhold, G Hüper, T J Matthews, et al.

International Journal of Obesity (2005)|August 18, 2016

Maternal obesity programs mitochondrial and lipid metabolism gene expression in infant umbilical vein endothelial cellsS M R Costa, E Isganaitis, T J Matthews, et al.

Cancer|April 1, 1987

Familial Hodgkin's disease. A clinical and laboratory investigationS J Robertson, J T Lowman, S Grufferman, et al.

Journal of Virology|June 1, 1992

Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolatesM Robert-Guroff, K Aldrich, R Muldoon, et al.

Journal of Virology|December 16, 1998

Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodiesH M Vu, D Myers, R de Lorimier, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptidesT J Palker, M E Clark, A J Langlois, et al.

Pageof 17

Showing results (121-130 of 161) with videos related to

Sort By:

Pageof 17

Journal of Virology|November 13, 1999

Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificityC C LaBranche, T L Hoffman, J Romano, et al.

AIDS Research and Human Retroviruses|May 19, 2006

Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2T Melby, P Sista, R DeMasi, et al.

Science (New York, N.Y.)|December 14, 1990

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1K Javaherian, A J Langlois, G J LaRosa, et al.

AIDS Research and Human Retroviruses|October 1, 1995

Induction of HIV type 1 neutralizing and env-CD4 blocking antibodies by immunization with genetically engineered HIV type 1-like particles containing unprocessed gp160 glycoproteinsB Rovinski, L Rodrigues, S X Cao, et al.

Virology|May 1, 1984

Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymusK J Weinhold, G Hüper, T J Matthews, et al.

International Journal of Obesity (2005)|August 18, 2016

Maternal obesity programs mitochondrial and lipid metabolism gene expression in infant umbilical vein endothelial cellsS M R Costa, E Isganaitis, T J Matthews, et al.

Cancer|April 1, 1987

Familial Hodgkin's disease. A clinical and laboratory investigationS J Robertson, J T Lowman, S Grufferman, et al.

Journal of Virology|June 1, 1992

Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolatesM Robert-Guroff, K Aldrich, R Muldoon, et al.

Journal of Virology|December 16, 1998

Nuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodiesH M Vu, D Myers, R de Lorimier, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptidesT J Palker, M E Clark, A J Langlois, et al.

Pageof 17